IXCHIQ DIN 02548984
Status: Marketed
Holder: VALNEVA AUSTRIA GMBH
Available to quote
Health Canada record
| Active ingredient(s) | CHIKUNGUNYA VIRUS LIVE-ATTENUATED 3 Log10 TCID50 |
|---|---|
| Dosage form | Powder For Solution |
| Route | Intramuscular |
| Schedule | SCHEDULE D |
| Class | Human |
| ATC | J07BP01 CHIKUNGUNYA, LIVE ATTENUATED |
| Original market date | 28-Oct-2024 |
| Current status date | 28-Oct-2024 |
| Source | Health Canada DPD |
Establishment licence of the holder
Valneva Austria GmbH — licence , not currently licensed, last inspection rating C (2025-09-24).
No Canadian shortage report is currently matched to this DIN.
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 33480 | 2024-06-20 | New Drug Submission (NDS) |